Marie-Anne Rameix-Welti

Université Paris Saclay

SCHOLARLY PAPERS

2

DOWNLOADS

289

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Genotypic and Phenotypic Characterisation of Rsv after Nirsevimab Breakthrough Infections in a Large Multicentre Observational Real-World Study

Number of pages: 30 Posted: 16 Jul 2024
Hôpitaux de Paris (AP-HP) - Hôpital Henri Mondor, Université Paris Saclay, Université Paris Cité - Institut Pasteur, Hospices Civils de Lyon - Laboratoire de Virologie, University of Paris-Saclay - Institut Pasteur, Centre Hospitalier de Bretagne Sud - Laboratoire de biologie médicale, University of Saint Etienne - Centre Hospitalier Universitaire de Saint-Étienne, Université de Toulouse - CHU de Toulouse, CHU Caen, University of Paris-Saclay - Laboratoire de Microbiologie, Université Paris 7, Hôpital Saint Louis - Service de Virologie, University of Nantes - CHU Nantes, Université Clermont Auvergne - CHU Clermont-Ferrand, University Grenoble Alpes - Centre Hospitalier Universitaire de Grenoble (CHU Grenoble Alpes), CHU Rouen, Sorbonne University - Laboratoire de virologie, Université Paris VI Pierre et Marie Curie - Hôpital Saint-Antoine, Hôpital Necker-Enfants Malades, CHU Montpellier, CHRU Tours, Centre Hospitalier Victor Dupouy, CHRU Brest - Morvan, Université Paris Nord - Laboratoire de Microbiologie Clinique, Université d’Orléans, University of Bordeaux - CHU de Bordeaux, CHU Angers, CHU de Rennes - Department of Virology, affiliation not provided to SSRN, affiliation not provided to SSRN, Hôpital Paul-Brousse - Service de Virologie, Amiens Picardie University Hospital - Department of Virology, University of Lille - CHU Lille, University of Lorraine - CNRS, LCPME, F-54000, University of Limoges - CHU Limoges, University of Strasbourg - Federation of Translational Medicine of Strasbourg (FMTS), Hôpitaux de Paris (AP-HP) - Hôpital Henri Mondor, University Hospital of Henri-Mondor, APHP - Department of Microbiology, CHU de la Martinique, University of Paris-Saclay - Institut Pasteur, Université Paris Cité, Hôpital Henri Mondor - Université Paris-Est, "Viruses, Hepatology, Cancer" Research Unit, Université Paris Cité - Institut Pasteur, Université Paris Est Créteil (UPEC) - IMRB, Université Paris Saclay and Independent
Downloads 260 (233,864)

Abstract:

Loading...

RSV, breakthrough infection, monoclonal antibodies, nirsevimab, resistance

2.

The Potential Bias Introduced into COVID-19 Vaccine Effectiveness Studies at Primary Care Level Due to the Availability of SARS-CoV-2 Tests in the General Population

Number of pages: 28 Posted: 12 Nov 2024
Epiconcept, Epiconcept, Carlos III Institute of Health - Communicable Diseases Department, National Institute for Public Health and the Environment (RIVM), Semmelweis University, National Institute of Health Doutor Ricardo Jorge, Public Health Agency of Sweden, Croatian Institute of Public Health, Cantacuzino National Military Medical Institute for Research and Development, Consejería de Sanidad - Dirección General de Salud Pública, Robert Koch Institute - Department for Infectious Disease Epidemiology, Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, Health Service Executive, Universidad Pública de Navarra - IdiSNA, Navarra Institute for Health Research, NIVEL (Netherlands Institute for Health Services Research), Semmelweis University, National Health Institute Doutor Ricardo Jorge (INSA) - National Influenza Reference Laboratory, Public Health Agency of Sweden, Croatian Institute of Public Health, Cantacuzino National Military Medical Institute for Research and Development, Consejería de Sanidad - Dirección General de Salud Pública, Robert Koch Institute, Université Paris Saclay, Health Service Executive, Instituto de Salud Pública y Laboral de Navarra, National Institute for Public Health and the Environment (RIVM), National Institute for Public Health and the Environment (RIVM), European Centre for Disease Prevention and Control, European Centre for Disease Prevention and Control and Epiconcept
Downloads 29 (952,173)

Abstract:

Loading...

COVID-19, Vaccine effectiveness, Test-negative design, Self-test, Bias, Directed acyclic graph, Simulation